Protective and Disease-Enhancing Immune Responses to Respiratory Syncytial Vir

The National Institutes of Health, Centers for Disease Control and Prevention, and World Health Organization jointly sponsored a workshop on protective and disease-enhancing immune responses to respiratory syncytial virus (RSV). The primary purpose of the meeting was to discuss protective and diseas...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 1995-01, Vol.171 (1), p.1-7
Main Authors: Anderson, Larry J., Heilman, Carole A.
Format: Article
Language:English
Subjects:
Agency Reports
Animal models
Antibodies
Human respiratory syncytial virus
Immune response
Immunity
Infections
Respiratory syncytial virus vaccines
Respiratory syncytial viruses
Vaccination
Viruses
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The National Institutes of Health, Centers for Disease Control and Prevention, and World Health Organization jointly sponsored a workshop on protective and disease-enhancing immune responses to respiratory syncytial virus (RSV). The primary purpose of the meeting was to discuss protective and disease-enhancing immune responses to RSV in the context of opportunities and barriers to the development of RSV vaccines. Although both live attenuated and subunit vaccines have been developed, it is not yet clear if any of these vaccines will be safe and effective. The fact that neither the disease-enhancing nor the protective immune response to RSV is well understood or well characterized is an important barrier to development of these vaccines. Studies in animal model systems and newly developed immunologic tools, however, provide hope that these barriers can be overcome and a safe and effective RSV vaccine can be developed.
ISSN:0022-1899
1537-6613